Monashee Investment Management’s Ambrx Biopharma Inc AMAM Stock Holding History

Monashee Investment Management’s Portfolio AMAM Stock Details AMAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-207,500	Closed	-$2.95M	–	124
2023 Q4	$2.95M	Buy	207,500 +137,500	+196%	+$1.56M	0.52%	19
2023 Q3	$805K	Buy	+70,000	New	+$953K	0.34%	63
2021 Q3	–	Sell	-110,000	Closed	-$2.16M	–	402
2021 Q2	$2.16M	Buy	+110,000	New	+$1.87M	0.26%	111

Monashee Investment Management's AMAM Position: Q1 2024 in Review

Monashee Investment Management sold out of Ambrx Biopharma Inc (AMAM) in Q1 2024, closing a stake of 207,500 shares — an estimated $2.95M sold.

Monashee Investment Management first reported a position in AMAM in Q2 2021 and held it in 3 quarters. The position peaked at $2.95M in Q4 2023. 0 funds tracked by Wall St. Rank hold AMAM as of Q1 2024.

Monashee Investment Management reported no remaining Ambrx Biopharma Inc position as of Q1 2024 after selling out during the quarter.
Monashee Investment Management sold 207,500 Ambrx Biopharma Inc shares in Q1 2024, an estimated $2.95M.
Monashee Investment Management first reported a position in Ambrx Biopharma Inc in Q2 2021 and held it in 3 quarters.
Monashee Investment Management's Ambrx Biopharma Inc position peaked at $2.95M in Q4 2023.
0 funds tracked by Wall St. Rank held Ambrx Biopharma Inc as of Q1 2024.

Based on Monashee Investment Management's 13F filing for Q1 2024, filed 14 May 2024.